SEARCH

HOME / SEARCH / Nilotinib

iGMDRD190

Canonical SMILES: CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5

InChI: InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37)

InChI Key: HHZIURLSWUIHRB-UHFFFAOYSA-N

Loading, please wait...

Standard Name	CHEMBL	Pubchem CID	DRUGBANK ID	Drug Status	Drug Type
Standard NameNilotinib CHEMBLCHEMBL255863 CHEMBL1201740 Pubchem CID644241 DRUGBANK IDDB04868 Drug StatusAlone Drug TypeSmall Molecule

Drug Class:

Antineoplastic Agents Antineoplastic and Immunomodulating Agents BCRP/ABCG2 Inhibitors BCRP/ABCG2 Substrates Combined Inhibitors of CYP3A4 and P-glycoprotein Combined Inhibitors of CYP3A4 and P-glycoprotein (Strong)Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (moderate)Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Inhibitors (strong)Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strong)Cytochrome P-450 Enzyme Inducers Cytochrome P-450 Enzyme Inhibitors Heterocyclic Compounds Heterocyclic Compounds, 1-Ring Highest Risk QTc-Prolonging Agents Hyperglycemia-Associated Agents Immunosuppressive Agents Kinase Inhibitor Myelosuppressive Agents P-glycoprotein/ABCB1 Inhibitors P-glycoprotein/ABCB1 Substrates Protein Kinase Inhibitors QTc Prolonging Agents Tyrosine Kinase Inhibitors UGT1A1 Inhibitors

Drug Targets:

ABL1 (P00519)KIT (P10721)

Drug Pathways:

ABL signaling

Drug-model tissue-cancer distribution: Bubble Plot

Drug-gene pathway enrichments

Drug-gene GO enrichments

Drug-Gene: Aster Plot

Loading, please wait...

Gene ID	Gene Name	Model Num.
83940	TATDN1	1
2956	MSH6	1
103	ADAR	1
3845	KRAS	1

Showing 1 to 4 of 123 rows rows per page

Gene in drug-gene network: Network Plot

Models in Nilotinib

Loading, please wait...

	Model	Level	Reference ID	Tissue	Cancer	Drug	Clinical Response	Source
No matching records found

SITE

DATATYPES

CLASSFICATION

Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.